Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-10

Clinical Trial Update: Efficacy of Aspirin in Preventing Venous Thromboembolism [Phase 4]

View source ↗

Summary

Phase 4 study evaluating whether aspirin reduces venous thromboembolism after total joint arthroplasty; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | Conditions: Venous Thromboembolism (VTE), Total Joint Arthroplasty | Phase 4 | Status: COMPLETED